Wire · regulatory
FDA Warning Letter Signals New Scrutiny for AI-Powered Medical Software
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 12 October 2026 · Fusion42 review
The FDA issued a warning letter to O.N. Diagnostics for failing to submit a new premarket notification after significant updates to its AI-powered spine CT scan analysis software, including a new machine learning model, cloud migration, and related cybersecurity concerns. This case signals heightened FDA scrutiny on algorithm updates and architectural changes in software-based medical devices.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
FDA is now treating AI software updates and cloud migration as new products requiring fresh approvals. You must plan regulatory steps before changing algorithms or delivery methods to avoid losing market access or facing enforcement.
◆ Coverage
1 source · 12 Oct 2026
◆ Related on Wire
◆ Topics